BR0200876A - Preparação de antibiótico/antibióticos com liberação retardada de substância ativa - Google Patents
Preparação de antibiótico/antibióticos com liberação retardada de substância ativaInfo
- Publication number
- BR0200876A BR0200876A BR0200876-9A BR0200876A BR0200876A BR 0200876 A BR0200876 A BR 0200876A BR 0200876 A BR0200876 A BR 0200876A BR 0200876 A BR0200876 A BR 0200876A
- Authority
- BR
- Brazil
- Prior art keywords
- antibiotics
- antibiotic
- cycloalkyl
- aryl
- sulfonates
- Prior art date
Links
- 230000003115 biocidal effect Effects 0.000 title abstract 8
- 239000003242 anti bacterial agent Substances 0.000 title abstract 7
- 229940088710 antibiotic agent Drugs 0.000 title abstract 6
- 239000013543 active substance Substances 0.000 title abstract 3
- 230000003111 delayed effect Effects 0.000 title abstract 3
- -1 aryl sulfates Chemical class 0.000 abstract 11
- 239000002671 adjuvant Substances 0.000 abstract 3
- 125000002877 alkyl aryl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- PMZDQRJGMBOQBF-UHFFFAOYSA-N quinolin-4-ol Chemical compound C1=CC=C2C(O)=CC=NC2=C1 PMZDQRJGMBOQBF-UHFFFAOYSA-N 0.000 abstract 2
- 239000004098 Tetracycline Substances 0.000 abstract 1
- 150000008051 alkyl sulfates Chemical class 0.000 abstract 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 abstract 1
- 150000008052 alkyl sulfonates Chemical class 0.000 abstract 1
- 239000002647 aminoglycoside antibiotic agent Substances 0.000 abstract 1
- 125000005228 aryl sulfonate group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000007943 implant Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960002180 tetracycline Drugs 0.000 abstract 1
- 229930101283 tetracycline Natural products 0.000 abstract 1
- 235000019364 tetracycline Nutrition 0.000 abstract 1
- 150000003522 tetracyclines Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
- A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Transplantation (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
"PREPARAçãO DE ANTIBIóTICO/ANTIBIóTICOS COM LIBERAçãO RETARDADA DE SUBSTâNCIA ATIVA". A presente invenção refere-se a um preparado de antibiótico/antibióticos para implantes reabsorvíveis e não-reabsorvíveis para a medicina humana e veterinária, para tratamento de infecções locais microbiais nos tecidos duros e frouxos. O preparado de antibiótico/antibióticos de acordo com a invenção é uma mistura consistindo em pelo menos um componente de um representante dos sulfatos de alquila, sulfatos de arila, sulfatos de alquilarila, sulfatos de cicloalquila, sulfatos de alquilcicloalquila, sulfamatos de alquila, sulfamatos de cicloalquila, sulfamatos de alquilcicloalquila, sulfamatos de arila, sulfamatos de alquilarila, sulfonatos de alquila, ácido graxo-2-sulfonatos, sulfonatos de arila, sulfonatos de alquilarila, sulfonatos de cicloalquila, sulfonatos de alquilcicioalquila, dissulfatos de alquila, dissulfatos de cicloalquila, dissufonatos de alquila, dissulfonatos de cicloalquila, dissulfonatos de arila, dissulfonatos de alquilarila, trissulfonatos de arila, e trissulfonatos de alquilarila, assim como pelo menos um componente antibiótico do grupo dos antibióticos aminoglicosídeos, dos antibióticos lincosamida, dos antibióticos 4-quinolona, ou dos antibióticos tetraciclina e opcionalmente pelo menos um componente coadjuvante orgânico, anidro, e opcionalmente pelo menos um componente coadjuvante inorgânico, e opcionalmente pelo menos um componente coadjuvante biologicamente ativo. O preparado de antibiótico/antibióticos de acordo com a invenção apresenta uma liberação de substância ativa retardada.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10114244A DE10114244A1 (de) | 2001-03-22 | 2001-03-22 | Antibiotikum-/Antibiotika-Zubereitung mit retardierender Wirkstofffreisetzung |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0200876A true BR0200876A (pt) | 2003-03-11 |
Family
ID=7678691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0200876-9A BR0200876A (pt) | 2001-03-22 | 2002-03-20 | Preparação de antibiótico/antibióticos com liberação retardada de substância ativa |
Country Status (32)
Country | Link |
---|---|
US (1) | US6913764B2 (pt) |
EP (1) | EP1243257B1 (pt) |
JP (1) | JP4181331B2 (pt) |
CN (1) | CN100486589C (pt) |
AT (1) | ATE258431T1 (pt) |
AU (1) | AU768962B2 (pt) |
BG (1) | BG65467B1 (pt) |
BR (1) | BR0200876A (pt) |
CA (1) | CA2378490C (pt) |
CZ (1) | CZ302690B6 (pt) |
DE (2) | DE10114244A1 (pt) |
DK (1) | DK1243257T3 (pt) |
EE (1) | EE200200153A (pt) |
ES (1) | ES2213717T3 (pt) |
GE (1) | GEP20053447B (pt) |
HR (1) | HRP20020240B1 (pt) |
HU (1) | HUP0201045A2 (pt) |
IL (1) | IL148703A (pt) |
IS (2) | IS6270A (pt) |
MD (1) | MD2550C2 (pt) |
MX (1) | MXPA02003007A (pt) |
NO (1) | NO331876B1 (pt) |
NZ (1) | NZ517922A (pt) |
PL (1) | PL204986B1 (pt) |
PT (1) | PT1243257E (pt) |
RU (1) | RU2264230C2 (pt) |
SA (1) | SA02230037B1 (pt) |
SK (1) | SK286493B6 (pt) |
TR (1) | TR200400244T4 (pt) |
UA (1) | UA71030C2 (pt) |
YU (1) | YU11802A (pt) |
ZA (1) | ZA200202254B (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10114245A1 (de) * | 2001-03-22 | 2002-10-02 | Heraeus Kulzer Gmbh & Co Kg | Herstellung und Verwendung einer Antibiotikum-/Antibiotika-Zubereitung |
DE10114244A1 (de) * | 2001-03-22 | 2002-10-02 | Heraeus Kulzer Gmbh & Co Kg | Antibiotikum-/Antibiotika-Zubereitung mit retardierender Wirkstofffreisetzung |
DE10318991A1 (de) * | 2003-04-25 | 2004-11-18 | Heraeus Kulzer Gmbh & Co. Kg | Poröser Körper mit antibiotischer Beschichtung, Verfahren zur Herstellung sowie Verwendung |
EP1694712A1 (en) * | 2003-12-04 | 2006-08-30 | University of Utah Research Foundation | Modified macromolecules and methods of making and using thereof |
CA2575988C (en) | 2004-08-04 | 2014-02-18 | Brookwood Pharmaceuticals, Inc. | Methods for manufacturing delivery devices and devices thereof |
DE102004060666B3 (de) | 2004-12-15 | 2006-03-30 | Heraeus Kulzer Gmbh | Antibiotikum/Antibiotika enthaltendes Knochenersatzmaterial mit retardierender Wirkstofffreisetzung |
DE102005002703C5 (de) | 2005-01-19 | 2013-07-04 | Heraeus Kulzer Gmbh | Antibiotische Beschichtung von Implantaten sowie Verfahren zur antibiotischen Beschichtung |
EP1940482B1 (de) * | 2005-10-27 | 2014-07-23 | Nexilis AG | Implantat enthaltend amino-bisphosphonate und verfahren zu dessen herstellung |
KR101315925B1 (ko) * | 2005-10-27 | 2013-10-08 | 토멘 메디칼 아게 | 치과용 임플란트 및 그의 제조 방법 |
US20070213835A1 (en) * | 2005-11-04 | 2007-09-13 | Markus Wimmer | Plastic implant impregnated with an antibiotic |
DE102006007245A1 (de) | 2006-02-15 | 2007-08-23 | Heraeus Kulzer Gmbh | Implantatmaterial |
DE102006037362B3 (de) * | 2006-08-09 | 2007-09-20 | Heraeus Kulzer Gmbh | Knochenersatzmaterial |
US7923021B2 (en) * | 2007-07-24 | 2011-04-12 | University Of Memphis Research Foundation | Local delivery method and composition |
DE102007039871A1 (de) | 2007-08-21 | 2009-02-26 | Friedrich-Baur-Gmbh | Weichgewebe-Implantat mit antibakterieller Wirkung |
ES2718612T3 (es) | 2007-12-20 | 2019-07-03 | Evonik Corp | Procedimiento para preparar micropartículas que tienen un bajo volumen de disolvente residual |
CN101758337B (zh) * | 2009-12-03 | 2012-02-15 | 湖南阿斯达生化科技有限公司 | 一种助焊剂用非卤素活性剂 |
WO2013010045A1 (en) | 2011-07-12 | 2013-01-17 | Biotime Inc. | Novel methods and formulations for orthopedic cell therapy |
EA202090748A1 (ru) * | 2017-06-16 | 2020-08-11 | Борис Славинович ФАРБЕР | Биологически активные комбинаторные производные полисахаридов |
IL271777B1 (en) | 2017-07-07 | 2024-05-01 | Epicentrx Inc | Preparations for intravenous administration of medical substances |
IL256312A (en) | 2017-12-14 | 2018-01-31 | Omrix Biopharmaceuticals Ltd | Antibacterial preparations containing minocycline and oxidized cellulose |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US356759A (en) * | 1887-02-01 | Paul gmehlikt | ||
US3091572A (en) | 1962-07-16 | 1963-05-28 | Schering Corp | Gentamycin and method of production |
GB1120992A (en) * | 1965-04-24 | 1968-07-24 | Fisons Pharmaceuticals Ltd | Aerosol compositions |
ES315101A1 (es) | 1965-07-08 | 1966-01-01 | Folch Vazquez Conrado | Procedimiento de preparaciën de nuevos derivados de tetraciclina |
FR6476M (pt) | 1967-06-06 | 1968-11-18 | ||
DE2320373B2 (de) * | 1973-04-21 | 1978-04-06 | Merck Patent Gmbh, 6100 Darmstadt | Antibioticahaltiges Mittel und seine Verwendung als chirurgisches Kunststoffmaterial |
FR2272680B1 (pt) * | 1974-05-29 | 1978-07-21 | Hosbon Sa Lab | |
DE2511122B2 (de) * | 1975-03-14 | 1977-06-08 | Vorprodukt fuer die zubereitung von knochenzement | |
AR216922A1 (es) * | 1976-11-11 | 1980-02-15 | Merck Patent Gmbh | Procedimiento para la fabricacion de un medio quirurgico |
JPS5391113A (en) * | 1977-01-21 | 1978-08-10 | Meiji Seika Kaisha Ltd | Preparation of suppository of antibiotics |
DE2843963A1 (de) * | 1978-10-09 | 1980-04-24 | Merck Patent Gmbh | Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin |
DE3168032D1 (en) * | 1980-11-10 | 1985-02-14 | Alza Corp | Erodible polymer containing erosion rate modifier |
DE3206725A1 (de) * | 1981-05-13 | 1982-12-02 | Merck Patent Gmbh, 6100 Darmstadt | Schwer loesliche salze von aminoglykosidantibiotika |
DE3248328A1 (de) * | 1982-12-28 | 1984-06-28 | Bayer Ag, 5090 Leverkusen | Schwerloesliche salze von aminoglykosiden sowie diese enthaltende formulierungen mit verzoegerter wirkstoff-freigabe |
US5035891A (en) * | 1987-10-05 | 1991-07-30 | Syntex (U.S.A.) Inc. | Controlled release subcutaneous implant |
FR2668367B1 (fr) * | 1990-10-26 | 1994-05-13 | Centre Nal Recherc Scientifique | Medicament implantable a effet prolonge. |
US5709875A (en) | 1990-10-26 | 1998-01-20 | Centre National De La Rechierche Scientifique (C.N.R.S) | Implantable biodegradable material and process for its production |
CN2108030U (zh) * | 1991-07-13 | 1992-06-24 | 河北霸州市水利局下河口冲压件厂 | 折叠式爬楼拉液化气罐车 |
FR2697539B1 (fr) * | 1992-11-03 | 1994-12-02 | Pechiney Recherche | Méthode, dispositif et appareil de traitement de surface de corps de boîtes métalliques, en particulier an al ou ses alliages. |
DE4404018A1 (de) * | 1994-02-09 | 1995-08-10 | Merck Patent Gmbh | Protrahiert freisetzende Darreichungsformen enthaltend Clindamycin-Palmitat |
AU6439094A (en) * | 1994-04-06 | 1995-10-30 | Aktsionernoe Obschestvo Zakrytogo Tipa Firma "Assol" (Firma "Assol") | Pharmaceutical agent for local application and a method of obtaining same |
US5614206A (en) * | 1995-03-07 | 1997-03-25 | Wright Medical Technology, Inc. | Controlled dissolution pellet containing calcium sulfate |
US5674142A (en) * | 1996-04-16 | 1997-10-07 | Sram Corporation | Control cable adjustment device |
US5670142A (en) * | 1996-07-08 | 1997-09-23 | Donald Neudecker | Treatment for itch of chicken pox |
DE19713229A1 (de) * | 1997-04-01 | 1998-10-08 | Merck Patent Gmbh | Antibiotikumhaltige Knochenzementpaste |
DE10114244A1 (de) * | 2001-03-22 | 2002-10-02 | Heraeus Kulzer Gmbh & Co Kg | Antibiotikum-/Antibiotika-Zubereitung mit retardierender Wirkstofffreisetzung |
-
2001
- 2001-03-22 DE DE10114244A patent/DE10114244A1/de not_active Ceased
-
2002
- 2002-02-13 MD MDA20020075A patent/MD2550C2/ro not_active IP Right Cessation
- 2002-02-15 IS IS6270A patent/IS6270A/is unknown
- 2002-02-15 IS IS6269A patent/IS2501B/is unknown
- 2002-02-19 GE GE4858A patent/GEP20053447B/en unknown
- 2002-02-20 YU YU11802A patent/YU11802A/sh unknown
- 2002-02-27 BG BG106454A patent/BG65467B1/bg unknown
- 2002-03-06 DK DK02005023T patent/DK1243257T3/da active
- 2002-03-06 TR TR2004/00244T patent/TR200400244T4/xx unknown
- 2002-03-06 EP EP02005023A patent/EP1243257B1/de not_active Expired - Lifetime
- 2002-03-06 AT AT02005023T patent/ATE258431T1/de active
- 2002-03-06 PT PT02005023T patent/PT1243257E/pt unknown
- 2002-03-06 ES ES02005023T patent/ES2213717T3/es not_active Expired - Lifetime
- 2002-03-06 DE DE50200223T patent/DE50200223D1/de not_active Expired - Lifetime
- 2002-03-08 CZ CZ20020871A patent/CZ302690B6/cs not_active IP Right Cessation
- 2002-03-14 IL IL148703A patent/IL148703A/en not_active IP Right Cessation
- 2002-03-18 SK SK389-2002A patent/SK286493B6/sk not_active IP Right Cessation
- 2002-03-19 US US10/100,839 patent/US6913764B2/en not_active Expired - Fee Related
- 2002-03-20 BR BR0200876-9A patent/BR0200876A/pt not_active IP Right Cessation
- 2002-03-20 ZA ZA200202254A patent/ZA200202254B/xx unknown
- 2002-03-20 MX MXPA02003007A patent/MXPA02003007A/es active IP Right Grant
- 2002-03-20 NO NO20021390A patent/NO331876B1/no not_active IP Right Cessation
- 2002-03-21 HU HU0201045A patent/HUP0201045A2/hu unknown
- 2002-03-21 PL PL352920A patent/PL204986B1/pl not_active IP Right Cessation
- 2002-03-21 NZ NZ517922A patent/NZ517922A/en not_active IP Right Cessation
- 2002-03-21 RU RU2002107208/15A patent/RU2264230C2/ru active
- 2002-03-21 HR HR20020240A patent/HRP20020240B1/xx not_active IP Right Cessation
- 2002-03-21 AU AU27554/02A patent/AU768962B2/en not_active Ceased
- 2002-03-21 UA UA2002032263A patent/UA71030C2/uk unknown
- 2002-03-22 EE EEP200200153A patent/EE200200153A/xx unknown
- 2002-03-22 CA CA002378490A patent/CA2378490C/en not_active Expired - Fee Related
- 2002-03-22 CN CNB021080305A patent/CN100486589C/zh not_active Expired - Fee Related
- 2002-03-22 JP JP2002081307A patent/JP4181331B2/ja not_active Expired - Fee Related
- 2002-04-02 SA SA02230037A patent/SA02230037B1/ar unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0200876A (pt) | Preparação de antibiótico/antibióticos com liberação retardada de substância ativa | |
Neut et al. | Residual gentamicin-release from antibiotic-loaded polymethylmethacrylate beads after 5 years of implantation | |
BR0201099A (pt) | Fabricação e uso de antibiótico/preparação de antibióticos | |
Alberts et al. | Open tibial fractures: faster union after unreamed nailing than external fixation | |
BRPI0608840B8 (pt) | composição farmacêutica compreendendo uma difenil uréia substituída por ômega-carboxiarila, e seu processo de preparação | |
BRPI0412526A (pt) | composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica | |
Rutledge et al. | Treatment of osteomyelitis with local antibiotics delivered via bioabsorbable polymer | |
BRPI0418351A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, métodos de limitar a proliferação celular em um humano ou animal, de tratamento de um humano ou animal sofrendo de cáncer, de tratamento de profilaxia de cáncer, de tratamento de um humano ou animal sofrendo de uma doença neoplásica, de tratamento de um humano ou animal sofrendo de uma doença prolifetativa de tratamento de cáncer, para o tratamento de infecções associadas com cáncer, para o tratamento profilático de infecções associadas com cáncer, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, método de inibir a chk1 quinase, e, processo para a preparação de um composto ou um sal farmaceuticamente aceitável do mesmo | |
BR0317888A (pt) | Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos | |
BR0318600A (pt) | conjunto implantável para osteossìntese, e, conjunto com pelo menos duas placas de osteossìntese e parafusos ósseos | |
BR0209658A (pt) | Derivados de 4-amino-5-fenil-7-1ciclobutil-pirrolo [2,3-d] pirimidina | |
BRPI0113042B8 (pt) | composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato | |
BRPI0812504B8 (pt) | composto para profilaxia ou tratamento de doença ou condição associada a receptor de canabinoides em sujeito mamífero | |
CA2454584A1 (en) | Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient | |
BR0311931A (pt) | Composto, composição farmacêutica, uso de um composto, e, método para tratar uma doença ou condição mediada com hppar em um paciente | |
AR057099A1 (es) | Una forma cristalina, un proceso de preparacion y composicion farmaceutica | |
Kanellakopoulou et al. | Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a synthetic carrier of calcium sulphate (Stimulan®) releasing moxifloxacin | |
Farnsworth et al. | The effect of implanting gentamicin‐impregnated polymethylmethacrylate beads in the tarsocrural joint of the horse | |
BR0312453A (pt) | Implante para o transporte e a liberação de agentes farmacologicamente ativos e processo para a produção do mesmo | |
Merkatoris et al. | In vitro elution of penicillin, ampicillin, tetracycline, tulathromycin, and florfenicol from plaster of Paris beads | |
EA200601368A1 (ru) | Макролиды, обладающие противовоспалительной активностью | |
BR9912816A (pt) | Composição terapêutica à base de flavonóides, tencionada para uso no tratamento de tumores por agentes citotóxicos | |
BR9906975A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processo para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero | |
UY27947A1 (es) | Prófarmaco ihnibidor de beta-lactamasa | |
RU2343925C2 (ru) | Способ профилактики послеоперационного остеомиелита |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUI DADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011. |